Stebbins, Glenn T.

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 7,536

White matter changes in mild cognitive impairment and AD: a diffusion tensor imaging study

Medina, D., deToledo-Morrell, L., Urresta, F., Gabrieli, J. D. E., Moseley, M., Fleischman, D., Bennett, D. A., Leurgans, S., Turner, D. A., & Stebbins, G. T. (2006) · Neurobiology of Aging

Dementia and Cognitive Impairment ResearchAdvanced Neuroimaging Techniques and Applications

Cited by 492

Hallucinations in Parkinson disease

Diederich, N. J., Fénelon, G., Stebbins, G., & Goetz, C. G. (2009) · Nature Reviews Neurology

Hallucinations in medical conditionsParkinson's Disease Mechanisms and Treatments

Cited by 312

Diffusion tensor imaging in Alzheimer’s disease and mild cognitive impairment.

Stebbins, G. T., & Murphy, C. M. (2009) · Behavioural Neurology

Dementia and Cognitive Impairment ResearchAdvanced Neuroimaging Techniques and Applications

Cited by 245

TikTok Tics: A Pandemic Within a Pandemic

Olvera, C., Stebbins, G. T., Goetz, C. G., & Kompoliti, K. (2021) · Movement Disorders Clinical Practice

Obsessive-Compulsive Spectrum DisordersSocial Media in Health Education

Cited by 158

Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies

Goldman, J. G., Goetz, C. G., Brandabur, M., Sanfilippo, M., & Stebbins, G. T. (2008) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 109

Visual plus nonvisual hallucinations in Parkinson's disease: Development and evolution over 10 years

Goetz, C. G., Stebbins, G. T., & Ouyang, B. (2011) · Movement Disorders

Hallucinations in medical conditionsParkinson's Disease Mechanisms and Treatments

Cited by 91

Understanding visual hallucinations: A new synthesis

Collerton, D., Barnes, J., Diederich, N. J., Dudley, R., ffytche, D., Friston, K., Goetz, C. G., Goldman, J. G., Jardri, R., Kulisevsky, J., et al. (2023) · Neuroscience & Biobehavioral Reviews

Hallucinations in medical conditionsVisual perception and processing mechanisms

Cited by 83

The qualification of an enrichment biomarker for clinical trials targeting early stages of Parkinson’s disease

Stephenson, D., Hill, D., Cedarbaum, J. M., Tome, M., Vamvakas, S., Romero, K., Conrado, D. J., Dexter, D. T., Seibyl, J., Jennings, D., et al. (2019) · Journal of Parkinson’s Disease

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 46